Back to Zürcher Kantonalbank Zürcher Kantonalbank

VKTXVKTX

Showing 8 of 28 quarters

Position history for Zürcher KantonalbankZürcher Kantonalbank's holdings in Viking Therapeutics, Inc.

Yes. Zürcher Kantonalbank holds 50,273 shares of VKTX (Viking Therapeutics), worth $2M, as of its Q2 2026 13F filing. It increased the position by 3,487 shares (+7.5%) from Q1 2026. Zürcher Kantonalbank has held VKTX since Q1 2023, across 14 quarterly 13F filings.

Current Value

$2M

Current Shares

50,273

Total Value Change

+$516,226

Total Shares Change

+27,450

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
50,273
+7.5%
$2M0.0%$39.01
28
2026-Q1
Increased
46,786
+27.2%
$1.5M0.0%$32.54
32
2025-Q4
Increased
36,777
+2.7%
$1.3M0.0%$35.18
26
2025-Q3
Increased
35,809
+10.0%
$941,0610.0%$26.28
27
2025-Q2
Increased
32,545
+6.9%
$862,4430.0%$26.50
27
2025-Q1
Increased
30,446
+13.5%
$735,2710.0%$24.15
28
2024-Q4
Increased
26,835
+17.6%
$1.1M0.0%$40.24
29
2024-Q3
Increased
22,823
+2.9%
$1.4M0.0%$63.31
26

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used